ROS-Responsive Nanoparticle Drug Release in Wound Inflammation

Wound Microenvironment

Inflammation intensity (ROS source) 1.2

ROS diffusion coefficient 0.25

Nanoparticle Dose

ROS-sensitivity (K_d, lower = more sensitive) 1.00

Nanoparticle dose (count) 300

Live Readouts

Drug released

0.0%

Peak ROS (a.u.)

0.00

Particles fully triggered (D > 90%)

0 / 300

How it works

Chronically inflamed or infected wounds sustain elevated reactive-oxygen-species (ROS) levels (H₂O₂, superoxide) released by neutrophils and macrophages. ROS-responsive nanocarriers exploit this: their shell contains oxidation-labile linkages (e.g. thioketal or arylboronate esters) that are intact in healthy tissue but cleave in a ROS-rich wound bed, releasing the payload only where it is needed.

The wound's ROS field follows a 2D reaction-diffusion equation, solved here on a grid with an explicit finite-difference scheme (sub-stepped for numerical stability):

∂C/∂t = D∇²C + S(x,z) − λC

where S is production by the inflamed core (set by the intensity slider), D is the diffusion coefficient, and λ is a fixed scavenging/decay rate. Each nanoparticle samples the local concentration C beneath it and degrades with saturating Hill-type kinetics:

dD/dt = k · Cⁿ/(Kdⁿ + Cⁿ) · (1 − D),  n = 2

D is the particle's degraded fraction (0→1); its drug-release fraction is modeled as tracking D directly, matching the burst-then-plateau shape seen in real Korsmeyer–Peppas release data. Lower K_d means the shell responds to a smaller ROS trigger — a "hair-trigger" design useful for early-stage inflammation, at the cost of possibly releasing prematurely.

Intensity — how much ROS the inflamed core produces per second; a proxy for infection/inflammation severity.
Diffusion — how far the ROS signal spreads before decaying, controlling how localized triggered release stays.
Sensitivity (K_d) — the ROS concentration at which a particle is half-degraded.
Dose — number of nanoparticles seeded across the wound bed.

Real-world relevance: this stimuli-responsive triggering strategy is used experimentally to deliver antimicrobials, antioxidants and growth factors selectively to inflamed wound tissue while sparing healthy skin.

Intact nanoparticle Degraded / releasing High local ROS

⚠ Couldn't load the 3D engineThree.js failed to load from the CDN. Check your connection and reload.